PATIENT PORTAL

Under construction

 

 

 

News

Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services Sysmex, the Foundation for Biomedical Research and Innovation at Kobe, and Kyoto University Begin Joint Research on Technologies for Diagnosing Immunological Diseases Sysmex Launches New Products in Its System for the Testing of Cancer Lymph Node Metastasis Using the OSNA™ Method: Gene Amplification Detector RD-200 and LYNOAMP™ CK19 Sysmex Group Formulates New Long-Term Management Goals Sysmex Announces “Sysmex Eco-Vision 2025” Sysmex to Establish Bio-Diagnostic Reagent Center Sysmex Employee to Receive the “Medal with Purple Ribbon,” a Spring 2018 Medal of Honor Sysmex to Launch JICA Project in the Republic of Ghana: "Collaboration Program for Disseminating Automated Urinalysis Diagnosis Technology” Sysmex Europe GmbH to Transfer Management of All European Installations of The DigniCap Scalp Cooling System Back to Dignitana AB Sysmex Launches Caresphere™, a New Network Solution Advanced Medical Care Approval Received for Multiplex Gene Panel Testing to Advancing Personalized Medicine Sysmex Formulates New Corporate Message:“Lighting the way with diagnostics” Japan’s first-ever industry-academia alliance to realize the development of innovative medicine in Japan OncoBEAM™ RAS CRC liquid biopsy test now reimbursed in Germany by BARMER Sysmex to Be Special Sponsor of the Kobe Marathon 2018 Sysmex feiert 50-jähriges Jubiläum Sysmex Middle East in Medlab exhibition 5-8 February 2018 in Dubai- UAE In depth: Performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS liquid biopsy testing for KRAS mutation detection presented at ASCO GI 2018 In depth: Performance comparison of OncoBEAM RAS CRC and Idylla ctKRAS liquid biopsy testing for KRAS mutation detection presented at ASCO GI 2018
Sysmex XN – TAILORING YOUR HAEMATOLOGY
See the scalability of XN
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
See our collection
Sysmex XN – TAILORING YOUR HAEMATOLOGY
See the scalability of XN